Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jun 4;96(11):1716-22.
doi: 10.1038/sj.bjc.6603774. Epub 2007 May 29.

Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma

Y S Lau  1 , I E Adamopoulos, A Sabokbar, H Giele, C L M H Gibbons, N A Athanasou
Affiliations

Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma

Y S Lau et al. Br J Cancer. .

Abstract

Cellular mechanisms that account for tumour osteolysis associated with Ewing's sarcoma are uncertain. Osteoclasts are marrow-derived multinucleated cells (MNCs) that effect tumour osteolysis. Osteoclasts are known to form from macrophages by both receptor activator for nuclear factor-kappaB (RANK) ligand (RANKL)-dependent and -independent mechanisms. In this study, our aim has been to determine whether tumour-associated macrophages (TAMs) isolated from Ewing's sarcoma are capable of differentiating into osteoclasts and to characterise the cellular and humoral mechanisms whereby this occurs. Tumour-associated macrophages were isolated from two Ewing's sarcomas and cultured on both coverslips and dentine slices for up to 21 days with soluble RANKL and macrophage colony stimulating factor (M-CSF). Osteoclast formation from TAMs (CD14+) was evidenced by the formation of tartrate-resistant acid phosphatase (TRAP) and vitronectin receptor (VNR)-positive MNCs, which were capable of carrying out lacunar resorption. This osteoclast formation was inhibited by the addition of bisphosphonates. Both Ewing's sarcoma-derived fibroblasts and some bone stromal cells expressed RANKL and supported osteoclast formation by a contact-dependent mechanism. We also found that osteoclast differentiation occurred when Ewing's TAMs were cultured with tumour necrosis factor (TNF)-alpha in the presence of M-CSF and that TC71 Ewing's sarcoma cells stimulated osteoclast formation through the release of a soluble factor, the action of which was abolished by an antibody to TNF-alpha. These results indicate that TAMs in Ewing's sarcoma are capable of osteoclast differentiation by both RANKL-dependent and TNF-alpha-dependent mechanisms and that Ewing's sarcoma cells produce osteoclastogenic factor(s). Our findings suggest that anti-resorptive and anti-osteoclastogenic therapies may be useful in inhibiting the osteolysis of Ewing's sarcoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) TRAP+ and (B) VNR+ MNCs formed after 14 days when Ewing's sarcoma-derived TAMs were cultured in the presence of RANKL and M-CSF. (C) Extensive lacunar resorption on a dentine slice after TAMs were cultured for 21 days in the presence of RANKL and M-CSF (Toluidine blue staining). (D) No resorption was seen on dentine in 21-day TAM cultures when RANKL was omitted (toluidine blue staining). Zoledronate-treated cultures showed a similar appearance. Bars=50 μm.
Figure 2
Figure 2
(A) TRAP+ and (B) VNR+ MNCs in a 14-day coculture of human PBMCs with Ewing's sarcoma-derived fibroblasts in the presence of M-CSF. (C) Lacunar resorption pits formed on a dentine slice in a 21-day coculture of human PBMCs with Ewing's sarcoma-derived fibroblasts in similar conditions. Bars=50 μm.
Figure 3
Figure 3
Expression of RANKL, OPG and TRAIL mRNA by fibroblasts derived from Ewing's sarcoma and TC71 cells. Reverse transcription-polymerase chain reaction products were fractionated on agarose gel. Lane 1, positive control; lane 2, negative control; lane 3, TC71; lanes 4–5, Ewing's sarcoma-derived fibroblasts from two patients; lanes 6–8, normal bone stromal cells.
Figure 4
Figure 4
(A) % surface area (SA) resorption formed in human PBMC cultures incubated with M-CSF and TC71 conditioned medium relative to positive control (PBMC cultures with M-CSF and RANKL). Error bars denote s.e.m. (n=3). (B)The effect of OPG, RANK: Fc and neutralising antibodies to TNF-α on resorption in PBMC cultures incubated with M-CSF and 10% TC71 conditioned medium. The data represent the mean % surface area (SA) lacunar resorption relative to the positive control (PBMC cultures with M-CSF and RANKL). Error bars denote s.e.m. (n=6).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adamopoulos I, Edwards J, Ferguson D, Wordsworth P, Carr A, Athanasou NA (2006) Synovial fluid macrophages are capable of osteoclast formation and resorption. J Pathol 208: 35–43 - PubMed
    1. Athanasou NA (1996) The cellular biology of bone-resorbing cells (Review). J Bone Joint Surg [A] 78A: 1096–1112 - PubMed
    1. Athanasou NA, Quinn J (1990) Immunophenotypic difference between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 43: 997–1004 - PMC - PubMed
    1. Bugelski PJ, Corwin SP, North SM, Kirsh RL, Nicolson GL, Poste G (1987) Macrophage content of spontaneous metastases at different stages of growth. Cancer Res 47: 4141–4145 - PubMed
    1. Clohisy DR, Ogilvie CM, Carpenter RJ, Ramnaraine MLR (1996) Localised tumor-associated osteolysis involves the recruitment and activation of osteoclasts. J Orthop Res 14: 2–6 - PubMed

Publication types

MeSH terms